stem cell negative
stem cell negative, Total:87 items.
The international standard classification for "stem cell negative" includes: Biology. Botany. Zoology , Animal husbandry and breeding , Laboratory medicine , Protection against crime .
The Chinese standard classification for "stem cell negative" includes: Basic standards and general methods , Basic Subject in general , Cereal crop and forage crop in general , Other cash crops , Pharmaceutical in general , Domestic animal and poultry , Technical Management , Medical laboratory equipment , Crime judging technology .
Group Standards of the People's Republic of China
- T/SRA 003-2019 Standards for Quality Assurance of Human Umbilical Cord Mesenchymal Stem Cells
- T/CIET 356-2024 Specification for isolation and preparation of adipose mesenchymal stem cells
- T/LNSI 001-2023 Human amniotic mesenchymal stem cells
- T/CIET 502-2024 Preparation and quality identification of mesenchymal stem cells derived from human induced pluripotent stem cells
- T/CSCB 0001-2020 General requirements for stem cells
- T/CRHA 003-2021 Laboratory-General requirements for testing of human-derived stem cell
- T/CIQA 99-2024 Specifications for examination of cytokine-induced killer cells
- T/CRHA 002-2021 Human pluripotent stem cell derived small extracellular vesicles
- T/CMBA 015-2021 Guideline for Ethical Assessment of Stem Cell Sources
- T/CSCB 0005-2021 Human induced pluripotent stem cell
- T/CIQA 100-2024 Specifications for examination and production of extracellular vesicles derived from dental stem cells
- T/LNSI 011-2024 Human amniotic epithelial stem cell derived exosomes
- T/SRA 003-2020 Preparation and Quality Control of Embryonic Stem Cell derived Marrow Mesenchymal Stem Cell
- T/CEAC 045-2024 Technical requirements for the application of stem cell exosomes in skin anti-aging
- T/CSCB 0004-2021 Human hematopoietic stem/progenitor cell
- T/QMHIPA 004-2022 Specification of Release Testing for Stem Cell-based Medicinal Products of Cell Preparation Center
- T/CEAC 057-2024 Technical Specifications for Stem Cell Exosome Drug Delivery
- T/SDHCST 003-2022 Specification of Quality management for stem cell-based products
- T/CRHA 001-2021 Human mesenchymal stem cell derived small extracellular vesicles
- T/CSCB 0003-2021 Human mesenchymal stem cell
- T/CEAC 039-2024 Stem cell identification methods
- T/LNSI 004-2023 Human cytokine induced killer cell
- T/SDHCST 005-2022 Technical Specification of identification for Artificially Induced Pluripotent Stem Cells
- T/CSCB 0002-2020 Human embryonic stem cell
- T/SRA 001-2019 Standards for establishment of seed cell bank of human adipose-derived mesenchymal stem cells
- T/CEAC 066-2024 Plant Stem Cell Product Development Guide
- T/LNSI 010-2024 Human amniotic mesenchymal stem cell derived exosomes
- T/SDHCST 004-2022 Technical Specification for Artificially Induced Pluripotent Stem Cells
- T/SRA 002-2019 Standards for Quality Assurance of Human Adipose-derived Mesenchymal Stem Cells
- T/CSSCR 002-2019 Human embryonic stem cell
- T/SDHCST 003-2021 Standard Practice for Preparation of Human Umbilical Cord/Placental Mesenchymal Stem Cells
- T/SBIAORG 001-2023 Criteria for quality control of exosomes from mesenchymal stem cells
- T/CMBA 014-2021 Guideline for autologous hematopoietic stem cell transplantation
- T/QGCML 4637-2024 Snail stem cell culture environment control system
- T/SDHCST 002-2021 Human umbilical cord/placental mesenchymal stem cell public library
- T/SRA 004-2021 Constrution and Managenment of Bone Marrow Mesenchymal Stem Cell Bank
- T/SDHCST 001-2022 Technical Specification for Artificially Induced Pluripotent Stem Cells to Differentiate into Neural Cells
- T/CAME 49-2022 Construction and equipment standard of hematopoietic stem cell transplantation ward
- T/FDSA 0073-2025 Specifications for the isolation and preparation of human muscle stem cells
- T/CSCB 0004-2022 Human neural stem cell
- T/CRHA 014-2022 Specification for menstrual blood-derived mesenchymal stem cells resource storage - Part 3:Quality evaluation and release of menstrual blood-derived mesenchymal stem cells products
- T/LNSI 006-2024 Human amniotic epithelial stem cell bank
- T/CIET 503-2024 Specification for preparation and quality identification of hepatic progenitor cells derived from human induced pluripotent stem cells
- T/CRHA 013-2022 Specification for menstrual blood-derived mesenchymal stem cells resource storage - Part 2:Isolation, processing and cryopreservation of menstrual blood-derived mesenchymal stem cells
- T/SBX 055-2022 Test methods for tumorigenicity of stem cell therapy products
- T/CIET 416-2024 Stem cell anti-aging product development guide
- T/CSCB 0001-2022 Technical Specification for Ethics Review of Human Stem Cell Research
- T/QGCML 4541-2024 Stem cell observation platform anti-shake device
- T/LNSI 002-2023 Human amniotic epithelial stem cells
- T/GDAAV 1112-2024 Technical specification for the preparation of equine mesenchymal stem cells
- T/CIQA 98-2024 Specifications for examination of human dental pulp stem cells
- T/CMBA 019-2022 Specification for informed consent for donors of stem cells
- T/YZXMR 001-2021 Isolation and culture method of dental pulp stem cells
- T/LTIA 10-2020 Regulations for Preparation of Lyophilized Powder from Human Umbilical Cord Mesenchymal Stem Cell
- T/CIET 413-2024 Umbilical cord mesenchymal stem cell preparation and quality control specifications
- T/CMEAS 033-2024 Quality control management specification for the establishment of clinical-grade human umbilical cord mesenchymal stem cell bank
- T/LNSI 007-2024 Human amniotic mesenchymal stem cell bank
- T/LNSI 004-2024 Human cytokine induced killer cell
- T/LNSI 008-2024 Human umbilical cord mesenchymal stem cells
- T/CI 307-2024 Quality requirements of mesenchymal stem cells for therapy
- T/CSCB 0007-2022 General requirements for production of extracellular vesicles derived from human stem cells
Jilin Provincial Standard of the People's Republic of China
- DB22/T 3203-2020 Stem Cell Quality Control Practice
- DB22/T 2394-2015 Preparation and identification of porcine induced pluripotent stem cells (iPSCs)
- DB22/T 3574-2023 Mesenchymal stem cell storage service specifications
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China
- GB/T 42466-2023 Biobanking technical requirement for management of pluripotent stem cells
- GB/T 35520-2017 Chemicals—Embryotoxicity—Embryonic stem cell test
- GB/T 38788-2020 Technical specification for establishment of porcine pluripotent stem cells
Professional Standard - Medicine
- YY/T 1452-2016 Dry hematology analyzer(centrifuge method)
Sichuan Provincial Standard of the People's Republic of China
- DB51/T 3217-2024 Construction and Management Standards for Human Embryonic Stem Cell Banks
- DB51/T 3216-2024 Quality Standard for Dental Pulp Origin Mesenchymal Stem Cells
Anhui Provincial Standard of the People's Republic of China
- DB34/T 4962-2024 Standardization of the whole process management of hematopoietic stem cell transplantation
Zhejiang Provincial Standard of the People's Republic of China
- DB33/T 2030-2017 Standards for construction and management of human mesenchymal stem cell bank
Shaanxi Provincial Standard of the People's Republic of China
- DB61/T 1497-2021 Standards for construction and management of human mesenchymal stem cell bank
Professional Standard - Hygiene
- WS/T 245-2005 Reference method for the enumeration of erythrocytes and leucocytes
Professional Standard - Public Safety Standards
- GA/T 1493-2018 General specifications for peeled epithelia collector in Forensics
UNKNOWN
- T11/CSSCR 001-2017 General requirements for stem cells
International Organization for Standardization (ISO)
- ISO 18162:2024 Biotechnology — Biobanking — Requirements for human neural stem cells derived from pluripotent stem cells
Danish Standards Foundation
- DANSK DS/ISO 18162:2024 Biotechnology – Biobanking – Requirements for human neural stem cells derived from pluripotent stem cells
British Standards Institution (BSI)
- BS ISO 18162:2024 Biotechnology. Biobanking. Requirements for human neural stem cells derived from pluripotent stem cells
- 23/30463781 DC BS ISO 18162. Biotechnology. Biobanking. Requirements for human neural stem cells derived from pluripotent stem cells
- 24/30469263 DC BS ISO 8472-2 Biotechnology. Data interoperability for stem cell data - Part 2: Key characteristics of stem cell data
- 25/30469922 DC BS ISO 20012 Biotechnology - Biobanking - Requirements for human natural killer cells derived from pluripotent stem cells
- BS ISO 8472-1:2024 Biotechnology. Data interoperability for stem cell data - Framework
American Society for Testing and Materials (ASTM)
- ASTM F1027-86(2007) Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices
Korean Agency for Technology and Standards (KATS)
- KS M ISO 4590-2018 Rigid cellular plastics — Determination of the volume percentage of open cells and of closed cells
- KS M ISO 4590:2018 Rigid cellular plastics — Determination of the volume percentage of open cells and of closed cells
Magyar Szabványügyi Testület
- MSZ 5278-1957 Medicinal plant tart cherry. Cherry Embryonic Stem Cells (Cerasi)
negative effect,Negative list,stem cell,stem cell negative,negative probe,Wyeth Negative,Negative List Substances,stem cells stem cells,negative emotion,stem cells stem cells,negative reports,negative sensitive information,Quantum Water Negative,Negative List Evaluation,Negative supervision,Nantong Negative,negative sci